Top menu
Main menu
Main Content
Cancer Biology Research Center
Tel Aviv University
Staff Directory
Student Portal
TAU Website
Inquiry Portal
Student Portal
Registration
Search
This site
Global search
About
About Us
We are CBRC
Dotan Research Center
CBRC Members
Science & Innovation
News and Media
News and Media
Newsroom
Media Coverage
Events
Past & Future Events
CBRC
Dotan Center
TAU
Galleries
Grants
Contact
Contact Information
Contact Us
Reaching Out
Research
Eradicating Deadly Brain Tumors by 'Starvation'
Sep 14th, 2022
רפואה ומדעי החיים
Awards for outstanding abstracts at CBRC 2021 2nd semester virtual seminar
Fifteen outstanding abstracts presented by TAU students at CBRC 2nd semester virtual seminar series, were selected for 1,500 NIS award
Jul 22nd, 2021
CBRC
Research
Common Medications May Reduce Risk of Metastases after Colon and Rectal Cancer
Dec 27th, 2022
Eradicating Deadly Brain Tumors by 'Starvation'
Awards for outstanding abstracts at CBRC 2021 2nd semester virtual seminar
Common Medications May Reduce Risk of Metastases after Colon and Rectal Cancer
Apr 20th, 2021
Breakthrough in the Battle Against Brain Cancer
Dec 27th, 2022
Common Medications May Reduce Risk of Metastases after Colon and Rectal Cancer
Apr 12th, 2021
2021 CBRC Grant to: Prof. Neta Erez, Prof. Adit Ben Baruch and Prof. Ruth Ashery-Padan
You are here
Homepage of Tel Aviv University
>
Cancer Biology Research Center
> News Lobby
NEWS
What are you interested in?
All topics
CBRC
Dotan Research Center
שיוך לתחומים (field_research_zone)
מוח
רפואה
שיוך לתחומים (field_news_belong_area)
CBRC
Dotan Research Center
Engineering
Exact Sciences
General
Life Sciences
Medicine
שיוך לתחומים חדש (field_belong_domains)
- Any -
CBRC
Dotan Research Center
Research
Jul 14th, 2024
Will Existing Drugs Stop Cancer's Bone Spread?
רפואה
Existing Meds may Prevent Bone Spread in Breast Cancer Patients
Mar 27th, 2024
Ronit Satchi-Fainaro Inducted into the 2024 Class of the AIMBE College of
The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Ronit Satchi-Fainaro, Ph.D., Director, Cancer Biology Research Center at Tel Aviv University to its College of Fellows
CBRC
Aug 1st, 2023
Destroying Cancer: new drug delivery system containing RNA therapy can target
Researchers from Tel Aviv University develop nanoparticles containg RNA molecules, similar to those used in the COVID-19 vaccine, that inhibit the ability of cancer cells to divide
CBRC
Jul 6th, 2023
BOG23: TAU Inaugurates the Dubrovsky Research Fund for Solid Cancers
The Fund will support tumor research on campus and beyond
CBRC
Feb 5th, 2023
Prof. Nadir Arber’s team successfully detected cancers at an early stage -
Congratulations to Prof. Arber and the team at IPCC at TLVMC
CBRC
Research
Nov 10th, 2022
Breakthrough Treatment May Improve Efficacy of Chemotherapy in Breast Cancer
רפואה
TAU-developed treatment may reduce risk for lung metastasis following chemo from 52% to only 6%
Research
Nov 10th, 2022
Improving the Well-being of Women with BRCA Gene, Responsible for Breast Cancer
רפואה
Unique technique found by Tel Aviv University researchers to improve emotional well-being of women with increased risk of breast cancer, assist in decision making
Research
Sep 29th, 2022
Slowing Down Skin Cancer
רפואה
רפואה
Tel Aviv University researchers decipher the mechanism that enables skin cancer to metastasize to the brain - delaying its spread by 80%
Research
Sep 14th, 2022
Eradicating Deadly Brain Tumors by 'Starvation'
מוח
Inhibiting energy supply to glioblastoma cells, resulted in tumor regression within days
Aug 9th, 2022
Tiny Molecule Makes Big Impact on Cancer Treatment
Newly discovered molecule may allow for more accessible and effective cancer immunotherapies
CBRC
Jul 27th, 2022
2022 Youdim Student Prize to Nimrod Rappoport
Rappoport, of the Blavatnik School of Computer Science, was awarded for his project "multi-omics cancer subtyping"
CBRC
Show More
Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing,
Contact us as soon as possible >>